You are here:

MS in the media - 23 December 2016

Published on

17 - 23 December 2016

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Falls and bladder problems

US research has found an association between having urinary urgency with incontinence and falls in people with MS.  The researchers point out that this shows the risk of falls is not solely limited to people with mobility or balance problems

Source: MedPage Today

MS Trust link: Falls
MS Trust link: Bladder incontinence

The World vs MS

An international competition has chosen a shortlist of three innovative ideas to tackle common MS related problems (the need to find toilets, mobility and heat intolerance).  Public voting on the shortlist opens in January and the winning idea will be developed further

Source: Wired

MS Trust link: Equipment and adaptations

Tysabri concentrations and PML

Dutch research has found that concentrations of Tysabri (natalizumab) in the blood are not higher in people before they are diagnosed with PML.  This suggests that altering dosing frequency may not have an effect on the risk of PML

Source: MDEdge

MS Trust link: Tysabri (natalizumab)

Ocrelizumab trial results published

Publication of papers with the results of trials in relapsing MS and primary progressive MS.  In the relapsing trial, relapse rates were almost half of those seen in the control group taking Rebif. In primary progressive (compare to placebo), fewer people showed progression at 12 weeks and at 24 weeks. 

Source: BBC
Source: Daily Telegraph
Source: MedPage Today

MS Trust link: Ocrelizumab

Breath test for diagnosis

Israeli led research suggests it has developed a way to distinguish a range of health conditions (including MS) from a breath test.  A trial in people with 17 different conditions or none was found to be 86% accurate.  Researchers hope that this may eventually have a role in diagnosis

Source: Newswise

MS Trust link: Diagnosing MS

Print this page